Five-year clinical findings for Essilor® Stellest ®

Five-year clinical findings for Essilor® Stellest ®

Recently released five year data shows continued efficacy of Stellest® lenses in controlling myopia progression and axial elongation.

The results showed:

· Over five years, Essilor® Stellest® lenses slowed myopia progression by 1.75D*1 and axial elongation by 0.72mm**1 on average for all subjects, compared to the extrapolated control group

· That the efficacy was sustained in older children (up to 18 years old), as the children who completed the fifth-year study were aged between 13-18 years.

Norbert Gorny, Chief Scientific Officer at EssilorLuxottica, said, “We are excited to share the five-year findings for Essilor® Stellest® as long-term clinical data is essential to showcase the continued efficacy and performance of the lens in children”.

The study will continue for two more years.

For more details ask your Essilor Account Manager. 

View More Here